Implications of Postprandial Glucose and Weight Control in People With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The International Diabetes Federation (IDF) recently published guidelines for the management of postmeal hyperglycemia. These guidelines were established in view of the risk of postmeal hyperglycemia for vascular events. Because of the rising incidence and prevalence of diabetes and its complications, the IDF took action to state useful strategies for the treatment of diabetes, focusing on the detection and therapy of postprandial hyperglycemia. Besides nonpharmacological measures (blood glucose self-control and diet), drugs such as short-acting insulinotropic agents (sulfonylureas and glinides), glucosidase inhibitors, insulin, and incretin-based therapies can specifically be used to act on postmeal glucose elevations. The specific action profiles of these agents are shown and discussed with respect to the IDF guidelines. Type 2 diabetes is a chronic and progressive disease that affects ∼250 million people worldwide today, with an increasing incidence in the years to come (1). With this epidemic dimension, type 2 diabetes is of global concern. Poor control of the disease is a leading cause of death in most developed countries and is associated with microvascular complications (renal failure and blindness due to retinopathy) and macrovascular complications (cardiovascular disease and stroke) as well as neurological complications such as diabetic neuropathy. Macrovascular complications are the major cause of death in type 2 diabetic patients (2–7). Numerous epidemiological studies have shown that postprandial hyperglycemia substantially adds to the micro- and macrovascular risk not only in type 1 and type 2 diabetes, but already in impaired glucose tolerance (2–4,8). The associations between postmeal hyperglycemia and markers of cardiovascular disease such as oxidative stress, inflammation, endothelial dysfunction, and carotid IMT have been well characterized. In addition, postprandial hyperglycemia has also been connected with the incidence of carcinomas and cognitive dysfunction in elderly type 2 diabetic patients (9–11). Large intervention trials …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624 · cited 3×
“Because of their unique mechanism of action, they can be given at any stage of type 2 diabetes, either as monotherapy (where they have even shown a reduction in the progression from the pre-diabetic state of impaired glucose tolerance to type 2 diabetes) or in combination with other agents (9,21,22).”
BackgroundMonnier, L., Lapinski, H., & Colette, C. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.881 · Cited by 1,461 · cited 1×
“Especially at lower A1C concentrations, the proportional contribution of postprandial glucose to A1C is greater than at higher A1C values (17).”
BackgroundGlucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Standards of Medical Care in Diabetes—2007
American Diabetes Association (2007) · Diabetes Care · doi:10.2337/dc07-s004 · Cited by 1,190
Hanefeld, M. (2004) · European Heart Journal · doi:10.1016/s0195-668x(03)00468-8 · Cited by 641
Outpatient Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: Scientific Review
DeWitt, D. E., & Hirsch, I. B. (2003) · JAMA · doi:10.1001/jama.289.17.2254 · Cited by 502 · cited 1×
“The fast-acting insulin analogs were developed to mimic the physiological insulin response after a meal with a better action profile than regular human insulin and can also be used for prandial insulin therapy (23).”
BackgroundGlucagon-like peptide-1: From extract to agent. The Claude Bernard Lecture, 2005
Holst, J. J. (2006) · Diabetologia · doi:10.1007/s00125-005-0107-1 · Cited by 228
Meta-analysis of the health effects of using the glycaemic index in meal-planning
Opperman, A. M., Venter, C. S., Oosthuizen, W., Thompson, R. L., & Vorster, H. H. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041203 · Cited by 192
Cited by
Personalized nutrition by prediction of glycemic responses
Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.001 · Cited by 2,929
Bread Affects Clinical Parameters and Induces Gut Microbiome-Associated Personal Glycemic Responses
Korem, T., Zeevi, D., Zmora, N., Weissbrod, O., Bar, N., Lotan-Pompan, M., Avnit-Sagi, T., Kosower, N., Malka, G., Rein, M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.002 · Cited by 318
Shapiro, H., Suez, J., & Elinav, E. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12501 · Cited by 56
“In addition to facilitating weight loss, diet plays an important role in maintaining healthy glucose homeostasis.(7,8) Diets aimed at preventing and treating hyperglycemia often take into account the meal carbohydrate content(9) and the glycemic index (GI),(10) which estimates the postprandial glycemic response (PPGR)…”
BackgroundIndividual variations in glycemic responses to carbohydrates and underlying metabolic physiology
Wu, Y., Ehlert, B., Metwally, A. A., Perelman, D., Park, H., Brooks, A. W., Abbasi, F., Michael, B., Celli, A., Bejikian, C., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03719-2 · Cited by 48
Taking Systems Medicine to Heart
Trachana, K., Bargaje, R., Glusman, G., Price, N. D., Huang, S., & Hood, L. E. (2018) · Circulation Research · doi:10.1161/circresaha.117.310999 · Cited by 41
Metadata
- Authors
- Gallwitz, B.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S322-S325
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2142879944
- Cited by
- 72
- References
- 10
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Implications of Postprandial Glucose and Weight Control in People With Type 2 Diabetes. https://app.cochat.ai/papers/10.2337/dc09-s331
- The paper
- Gallwitz, B. (2009). Implications of Postprandial Glucose and Weight Control in People With Type 2 Diabetes. Diabetes Care. https://doi.org/10.2337/dc09-s331
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.